BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 34307650)

  • 21. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic nephropathy: traditional to proteomic markers.
    Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
    Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection and treatment of diabetic nephropathy.
    Woredekal Y
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():999-1004. PubMed ID: 18806717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of sex hormones in diabetic nephropathy.
    Liu J; Liu Z; Sun W; Luo L; An X; Yu D; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1135530. PubMed ID: 37143724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model and clinical Manifestations: A Review.
    Wal P; Tyagi S; Pal RS; Yadav A; Jaiswal R
    Curr Diabetes Rev; 2023; 19(5):e260422204036. PubMed ID: 35993472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes.
    Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Chattipakorn SC; Chattipakorn N; Lungkaphin A
    Biomed Pharmacother; 2017 Oct; 94():176-187. PubMed ID: 28759755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
    Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-Date on Diabetic Nephropathy.
    Pelle MC; Provenzano M; Busutti M; Porcu CV; Zaffina I; Stanga L; Arturi F
    Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic nephropathy: A potential savior with 'rotten-egg' smell.
    Dugbartey GJ
    Pharmacol Rep; 2017 Apr; 69(2):331-339. PubMed ID: 28183033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic Nephropathy: a Tangled Web to Unweave.
    Magee C; Grieve DJ; Watson CJ; Brazil DP
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):579-592. PubMed ID: 28956186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetes mellitus and chronic kideny disease: modern diagnostics and treatment].
    Shestakova MV
    Vestn Ross Akad Med Nauk; 2012; (1):45-9. PubMed ID: 22550710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic nephropathy: What does the future hold?
    Montero RM; Covic A; Gnudi L; Goldsmith D
    Int Urol Nephrol; 2016 Jan; 48(1):99-113. PubMed ID: 26438328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic nephropathy: An update on pathogenesis and drug development.
    A/L B Vasanth Rao VR; Tan SH; Candasamy M; Bhattamisra SK
    Diabetes Metab Syndr; 2019; 13(1):754-762. PubMed ID: 30641802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic nephropathy in type 1 diabetes.
    Papadopoulou-Marketou N; Paschou SA; Marketos N; Adamidi S; Adamidis S; Kanaka-Gantenbein C
    Minerva Med; 2018 Jun; 109(3):218-228. PubMed ID: 29205998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.
    Ilyas Z; Chaiban JT; Krikorian A
    Rev Endocr Metab Disord; 2017 Mar; 18(1):21-28. PubMed ID: 28289965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting inflammation in diabetic nephropathy: a tale of hope.
    Moreno JA; Gomez-Guerrero C; Mas S; Sanz AB; Lorenzo O; Ruiz-Ortega M; Opazo L; Mezzano S; Egido J
    Expert Opin Investig Drugs; 2018 Nov; 27(11):917-930. PubMed ID: 30334635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.
    Johnson SA; Spurney RF
    Am J Physiol Renal Physiol; 2015 Nov; 309(10):F807-20. PubMed ID: 26336162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current practices in the management of diabetic nephropathy.
    Chan G; Tang SC
    J R Coll Physicians Edinb; 2013; 43(4):330-2; quiz 333. PubMed ID: 24350318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension and Diabetic Nephropathy.
    Skov J; Christiansen JS; Poulsen PL
    Endocr Dev; 2016; 31():97-107. PubMed ID: 26824664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.